Skip to content
Screener

Erasca, Inc. ERAS Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies

Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
-$649.7M-162%
Tango Therapeutics logo
Tango TherapeuticsTNGX
-$45.85M-14.6%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-$101.3M-41.9%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
-$43.6M+32.1%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$6.39B+1,424%
Enterprise value$6.39B+1,487%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.

The source filing: Erasca, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216788
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Other income (expense), net22(76)
Total other income (expense), net4,4714,664
Net loss$(183,440)$(30,966)
Net loss per share, basic and diluted$(0.60)$(0.11)
Weighted-average shares of common stock used in computing net loss per share, basic and diluted304,317,460283,260,289
Other comprehensive income (loss):
Unrealized (loss) gain on marketable securities, net(1,327)223
Comprehensive loss$(184,767)$(30,743)

Item 1. Financial Statements.

FAQ

What is Erasca, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
Erasca, Inc. (ERAS) reported comprehensive income (loss), net of tax, attributable to parent of -$184.77M in Q1 2026.
How has Erasca, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
Erasca, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 501.0% year-over-year, from -$30.74M to -$184.77M.
What is the long-term trend for Erasca, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
Over 4 years (2021 to 2025), Erasca, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 0.3% compound annual growth rate (CAGR), from -$122.93M to -$124.32M.
What does comprehensive income (loss), net of tax, attributable to parent mean?
Represents the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as unrealized gains or losses on securities. This metric provides a more holistic view of the company's financial performance by including valuation adjustments that bypass the traditional income statement. It is essential for assessing the total impact of financial market volatility on the company's net worth.

Ask your AI about Erasca, Inc.'s comprehensive income (loss), net of tax, attributable to parent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude